Liu Mingxia, Allegood Jeremy, Zhu Xuewei, Seo Jeongmin, Gebre Abraham K, Boudyguina Elena, Cheng Dongmei, Chuang Chia-Chi, Shelness Gregory S, Spiegel Sarah, Parks John S
From the Department of Internal Medicine, Section on Molecular Medicine, and.
the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298.
J Biol Chem. 2015 Mar 20;290(12):7861-70. doi: 10.1074/jbc.M114.631101. Epub 2015 Jan 27.
Apolipoprotein M (apoM), a plasma sphingosine 1-phosphate (S1P) carrier, associates with plasma HDL via its uncleaved signal peptide. Hepatocyte-specific apoM overexpression in mice stimulates formation of both larger nascent HDL in hepatocytes and larger mature apoM/S1P-enriched HDL particles in plasma by enhancing hepatic S1P synthesis and secretion. Mutagenesis of apoM glutamine 22 to alanine (apoM(Q22A)) introduces a functional signal peptidase cleavage site. Expression of apoM(Q22A) in ABCA1-expressing HEK293 cells resulted in the formation of smaller nascent HDL particles compared with wild type apoM (apoM(WT)). When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles and decreased plasma S1P and apoM were observed relative to expression of apoM(WT). Hepatocytes isolated from both apoM(WT)- and apoM(Q22A)-expressing mice displayed an equivalent increase in cellular levels of S1P, relative to LacZ controls; however, relative to apoM(WT), apoM(Q22A) hepatocytes displayed more rapid apoM and S1P secretion but minimal apoM(Q22A) bound to nascent lipoproteins. Pharmacologic inhibition of ceramide synthesis increased cellular sphingosine and S1P but not medium S1P in both apoM(WT) and apoM(Q22A) hepatocytes. We conclude that apoM secretion is rate-limiting for hepatocyte S1P secretion and that its uncleaved signal peptide delays apoM trafficking out of the cell, promoting formation of larger nascent apoM- and S1P-enriched HDL particles that are probably precursors of larger apoM/S1P-enriched plasma HDL.
载脂蛋白M(apoM)是一种血浆鞘氨醇-1-磷酸(S1P)载体,通过其未切割的信号肽与血浆高密度脂蛋白(HDL)结合。小鼠肝细胞特异性apoM过表达通过增强肝脏S1P合成和分泌,刺激肝细胞中更大的新生HDL以及血浆中更大的富含apoM/S1P的成熟HDL颗粒的形成。将apoM的谷氨酰胺22突变为丙氨酸(apoM(Q22A))引入了一个功能性信号肽酶切割位点。与野生型apoM(apoM(WT))相比,在表达ABCA1的HEK293细胞中表达apoM(Q22A)导致形成更小的新生HDL颗粒。当使用重组腺病毒在体内表达apoM(Q22A)时,相对于apoM(WT)的表达,观察到血浆HDL颗粒更小,血浆S1P和apoM减少。相对于LacZ对照,从表达apoM(WT)和apoM(Q22A)的小鼠中分离的肝细胞显示细胞内S1P水平有同等程度的增加;然而,相对于apoM(WT),apoM(Q22A)肝细胞显示apoM和S1P分泌更快,但与新生脂蛋白结合的apoM(Q22A)极少。在apoM(WT)和apoM(Q22A)肝细胞中,药理学抑制神经酰胺合成增加了细胞内鞘氨醇和S1P,但未增加培养基中的S1P。我们得出结论,apoM分泌是肝细胞S1P分泌的限速因素,其未切割的信号肽延迟了apoM从细胞内的转运,促进了更大的富含apoM和S1P的新生HDL颗粒的形成,这些颗粒可能是更大的富含apoM/S1P的血浆HDL的前体。